A point-of-care malaria drug resistance assay (UC Berkeley)

Facebook
Twitter
LinkedIn

BI Filler Photo-01We propose to develop a palm-sized microfluidic device which permits culturing of malaria-infected red blood cells under physiological conditions in suspension. The extent of parasitemia is determined by a label-free magneto-optic technique. Such a device will enable point-of-care antibiotic resistance assays for testing different malarial strains primarily targeting countries in the developing world.

More Winners

LEAD

Across Burkina Faso and Africa, the inadequacy of skills in the workplace greatly contributes to the non-utilization of the continent’s human potential. This issue, rooted

Read More »

Cashify (UC Berkeley)

Cashify from Big Ideas @ Berkeley on Vimeo. Cashify seeks to innovate what financial literacy means for over 65 million young adults. Cashify provides a

Read More »

SurgeCare

The incidence of surgical site infections (SSI) in low-middle income countries (LMIC) is up to six times higher than in developed countries. SSI can be

Read More »

© 2021 Blum Center for Developing Economies

Design by Joseph Kim